indomethacin has been researched along with ACD-MPV in 19 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study sought to determine the effect of combined treatment of hypoxia plus indomethacin on pulmonary vascular remodeling in fetal rats." | 7.77 | Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin. ( Du, LZ; Gu, WZ; Li, RY; Wu, XL; Xu, XF, 2011) |
| "When Indomethacin in a dosage of 175 mg/day was used to treat threatened premature labour more than 70% of cases carried on until 37 weeks." | 6.37 | [Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients]. ( Barrat, J; Bouillie, J; Boyer, F; Keskes, J; Marpeau, L; Pigné, A; Vincenti, O, 1988) |
| "This study sought to determine the effect of combined treatment of hypoxia plus indomethacin on pulmonary vascular remodeling in fetal rats." | 3.77 | Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin. ( Du, LZ; Gu, WZ; Li, RY; Wu, XL; Xu, XF, 2011) |
| "When Indomethacin in a dosage of 175 mg/day was used to treat threatened premature labour more than 70% of cases carried on until 37 weeks." | 2.37 | [Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients]. ( Barrat, J; Bouillie, J; Boyer, F; Keskes, J; Marpeau, L; Pigné, A; Vincenti, O, 1988) |
| "Indomethacin-treated animals had an increased saccular wall mass, decreased airspace mass, and a decreased capillary to saccular wall ratio (P less than 0." | 1.26 | Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation (PFC). ( Bloor, CM; Friedman, WF; Harker, LC; Kirkpatrick, SE, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, C | 1 |
| Chang, Q | 1 |
| Wu, H | 1 |
| Meng, F | 1 |
| Sharma, P | 1 |
| Beam, K | 1 |
| Levy, P | 1 |
| Beam, AL | 1 |
| Steflik, HJ | 1 |
| Wessler, LA | 1 |
| Shugart, WW | 1 |
| Wagner, CL | 1 |
| Selewski, DT | 1 |
| Twombley, KE | 1 |
| Newman, JC | 1 |
| Atz, AM | 1 |
| Annibale, DJ | 1 |
| Lopata, SM | 1 |
| Slaughter, JC | 1 |
| Gillam-Krakauer, M | 1 |
| Reese, J | 1 |
| Mahajan, CN | 1 |
| Afolayan, AJ | 1 |
| Eis, A | 1 |
| Teng, RJ | 1 |
| Konduri, GG | 1 |
| Bancalari, E | 1 |
| Jain, D | 1 |
| Xu, XF | 1 |
| Gu, WZ | 1 |
| Wu, XL | 1 |
| Li, RY | 1 |
| Du, LZ | 1 |
| Turner, GR | 1 |
| Levin, DL | 1 |
| Harker, LC | 1 |
| Kirkpatrick, SE | 1 |
| Friedman, WF | 1 |
| Bloor, CM | 1 |
| Yeh, TF | 1 |
| Thalji, A | 1 |
| Luken, L | 1 |
| Lilien, L | 1 |
| Carr, I | 1 |
| Pildes, RS | 1 |
| Molina, V | 1 |
| Krauel, J | 1 |
| Baraibar, R | 1 |
| Campistol, J | 1 |
| Maria, B | 1 |
| Oriot, D | 1 |
| Boussemart, T | 1 |
| Berthier, M | 1 |
| Bonneau, D | 1 |
| Coisne, D | 1 |
| Patole, S | 1 |
| Lee, J | 1 |
| Whitehall, J | 1 |
| Slavík, Z | 1 |
| Zborilová, B | 1 |
| Hruda, J | 1 |
| Marpeau, L | 1 |
| Keskes, J | 1 |
| Vincenti, O | 1 |
| Boyer, F | 1 |
| Bouillie, J | 1 |
| Pigné, A | 1 |
| Barrat, J | 1 |
| Demello, DE | 1 |
| Murphy, JD | 1 |
| Aronovitz, MJ | 1 |
| Davies, P | 1 |
| Reid, LM | 1 |
| Gersony, WM | 1 |
| Leititis, JU | 1 |
| Burghard, R | 1 |
| Gordjani, N | 1 |
| Wildberg, A | 1 |
| Seyberth, HW | 1 |
| Brandis, M | 1 |
2 reviews available for indomethacin and ACD-MPV
| Article | Year |
|---|---|
[Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients].
Topics: Abortion, Threatened; Acute Kidney Injury; Ductus Arteriosus, Patent; Female; Fetal Death; Fetus; Hu | 1988 |
Patent ductus arteriosus in the neonate.
Topics: Alprostadil; Blood Circulation; Clinical Trials as Topic; Digoxin; Ductus Arteriosus; Ductus Arterio | 1986 |
2 trials available for indomethacin and ACD-MPV
| Article | Year |
|---|---|
Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosus.
Topics: Birth Weight; Blood Gas Analysis; Gestational Age; Humans; Hydrogen-Ion Concentration; Indomethacin; | 1981 |
Patent ductus arteriosus in the neonate.
Topics: Alprostadil; Blood Circulation; Clinical Trials as Topic; Digoxin; Ductus Arteriosus; Ductus Arterio | 1986 |
16 other studies available for indomethacin and ACD-MPV
| Article | Year |
|---|---|
Effect of fetal lung maturation on the treatment of patent ductus arteriosus in premature infants.
Topics: Ductus Arteriosus, Patent; Humans; Indomethacin; Infant; Infant, Newborn; Infant, Premature; Lung; P | 2023 |
PD(AI): the role of artificial intelligence in the management of patent ductus arteriosus.
Topics: Artificial Intelligence; Ductus Arteriosus, Patent; Humans; Indomethacin; Infant, Newborn; Infant, P | 2023 |
Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.
Topics: Ductus Arteriosus; Ductus Arteriosus, Patent; Humans; Indomethacin; Infant, Newborn; Infant, Prematu | 2023 |
The patent ductus arteriosus management debate: it's not over yet.
Topics: Ductus Arteriosus, Patent; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Persistent Feta | 2021 |
Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model.
Topics: Animals; Blotting, Western; Cyclooxygenase 1; Cyclooxygenase 2; Cytochrome P-450 Enzyme System; Endo | 2015 |
Management of Patent Ductus Arteriosus: Are We Looking at the Right Outcomes?
Topics: Ductus Arteriosus, Patent; Humans; Ibuprofen; Indomethacin; Infant, Newborn; Infant, Premature; Pers | 2017 |
Fetal pulmonary vascular remodeling in a rat model induced by hypoxia and indomethacin.
Topics: Actins; Animals; Animals, Newborn; Blotting, Western; Cardiovascular Agents; Disease Models, Animal; | 2011 |
Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn.
Topics: Animals; Blood Pressure; Ductus Arteriosus, Patent; Female; Fetus; Humans; Hypertension, Pulmonary; | 1984 |
Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation (PFC).
Topics: Animals; Animals, Newborn; Female; Fetus; Humans; Indomethacin; Infant, Newborn; Lung; Persistent Fe | 1981 |
[Persistance of fetal circulation. a case associated to maternal indomethacin administration (author's transl)].
Topics: Female; Hemodynamics; Humans; Indomethacin; Infant, Newborn; Labor, Obstetric; Male; Persistent Feta | 1980 |
[Prostaglandin and threat of premature labour inhibitors. 1. The possibilities and consequences (as given in the literature) (author's transl)].
Topics: Anti-Inflammatory Agents; Female; Humans; Indomethacin; Infant, Newborn; Labor, Obstetric; Maternal- | 1980 |
Paradoxical effect of inhaled nitric oxide in a newborn with pulmonary hypertension.
Topics: Administration, Inhalation; Diseases in Twins; Female; Humans; Hypoxia; Indomethacin; Infant, Newbor | 1993 |
Adenosine infusion in the management of a micropremi neonate with pulmonary hypertension.
Topics: Adenosine; Anti-Inflammatory Agents, Non-Steroidal; Ductus Arteriosus, Patent; Fatal Outcome; Humans | 1998 |
[The persistent pulmonary hypertension syndrome in neonates after intrauterine exposure to indomethacin].
Topics: Female; Fetus; Humans; Indomethacin; Infant, Newborn; Male; Persistent Fetal Circulation Syndrome; P | 1990 |
Effects of indomethacin in utero on the pulmonary vasculature of the newborn guinea pig.
Topics: Animals; Animals, Newborn; Ductus Arteriosus; Female; Guinea Pigs; Humans; Indomethacin; Infant, New | 1987 |
Effect of a modified fluid therapy on renal function during indomethacin therapy for persistent ductus arteriosus.
Topics: Creatinine; Fluid Therapy; Glomerular Filtration Rate; Humans; Indomethacin; Infant; Infant, Newborn | 1987 |